LexaGene Holdings Inc. Quarterly Operating Income (Loss) in USD from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LexaGene Holdings Inc. quarterly Operating Income (Loss) history and growth rate from Q3 2021 to Q4 2022.
  • LexaGene Holdings Inc. Operating Income (Loss) for the quarter ending November 30, 2022 was -$1.67M, a 38% increase year-over-year.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$1.67M +$1.02M +38% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 -$2.08M +$741K +26.3% Jun 1, 2022 Aug 31, 2022 10-Q 2022-10-18
Q4 2021 -$2.7M Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 -$2.82M Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.